P3.02F.04 Investigating the Role of Lactate Import and Metabolism in Non-Small Cell Lung Cancer

Authors: Cameron, R., Hammond, N., Kaur, M., Alsamraae, M., Bestvina, C., Garassino, M., Faubert, B.

Source: In Journal of Thoracic Oncology October 2024 19(10) Supplement:S302-S302

MA16.08 Impact of Site of CAN-2409 Injection Plus Continued Immune Checkpoint Inhibitor (ICI) In CI-resistant stage III/IV NSCLC

Authors: Sterman, D., Aggarwal, C., Alesi, E.R., Maldonado, F., Mehra, R., Bestvina, C., Reisenauer, J.S., Swartz, L.K., Puri, S., Ibrahim, O., Eapen, G., Duault, C., Del Valle, D.M., Kim-Schulze, S., Gonzalez-Kozlova, E., Gnjatic, S., Manzanera, A., Lopez, L., Dwyer, J., Rao, S., Nichols, G., Barone, F., Tak, P.P.

Source: In Journal of Thoracic Oncology October 2024 19(10) Supplement:S123-S123

MA01.04 AFT-46: CHIO3: Chemotherapy Combined with Immune Checkpoint Inhibitor for Operable Stage IIIA/B Non-Small Cell Lung Cancer

Authors: Martin, L., Wang, X., Kozono, D., Urbanic, J., Graziano, S., Osarogiagbon, R., Mehran, R.J., Wain, J., Bestvina, C., Gannon, J., Wolf, S., Stinchcombe, T., Patel, J.D.

Source: In Journal of Thoracic Oncology October 2024 19(10) Supplement:S52-S53

P1.25-02 Complete Pathologic Response (pCR) as a Surrogate Endpoint in Neoadjuvant Immunotherapy Clinical Trials for NSCLC: A Meta-analysis

Authors: Hines, J., Cameron, R., Torri, V., Cascone, T., Forde, P.M., Esposito, A., Vokes, E., Bestvina, C., Marina, G.C., Porcu, L.

Source: In Journal of Thoracic Oncology November 2023 18(11) Supplement:S268-S268

EP14.03-001 DARES: A Phase II Trial of Durvalumab and Ablative Radiation in Extensive Stage Small Cell Lung Cancer

Authors: Juloori, A., Gan, G., Zhang, J., Abazeed, M.E., Hara, J., Baschnagel, A.M., Traynor, A., Bassetti, M., Patel, J., Chmura, S., Bestvina, C.

Source: In Journal of Thoracic Oncology September 2022 17(9) Supplement:S540-S540

P50.04 Amivantamab in Combination With Chemotherapy in Patients With Advanced Non-Small Cell Lung Cancer (NSCLC)

Authors: Nagasaka, M., Goto, K., Gomez, J., Hida, T., Shu, C., Lee, C.K., Park, K., Cho, B.C., Lee, J., Ou, S., Bestvina, C., Natale, R., Haddish-Berhane, N., Bhattacharya, A., Verheijen, R., Agrawal, T., Knoblauch, R., Govindan, R.

Source: In Journal of Thoracic Oncology October 2021 16(10) Supplement:S1116-S1116

P24.04 Concordance of Tissue and Cell-Free DNA-Based Next-Generation Sequencing in Patients With Lung Adenocarcinoma

Authors: Tran, M., Strohbehn, G., Rouhani, S., Shergill, A., Hoffman, P., Patel, J., Segal, J., Vokes, E., Bestvina, C.

Source: In Journal of Thoracic Oncology October 2021 16(10) Supplement:S1032-S1032

P76.30 The Neutrophil-to-Lymphocyte Ratio is a Prognostic Biomarker in Patients with EGFR Mutated Advanced NSCLC

Authors: Rouhani, S., Yun, N., Bestvina, C., Gilmore, B., Ritz, E., Tarhoni, I., Batus, M., Borgia, J., Bonomi, P., Fidler, M.J.

Source: In Journal of Thoracic Oncology March 2021 16(3) Supplement:S599-S600

P14.27 Pathogenic Genomic Alterations of CDKN2A Predict Immunotherapy Resistance in NSCLC

Authors: Gutiontov, S., Turchan, W., Rouhani, S., Chervin, C. Soto, Segal, J., Bestvina, C., Donington, J., Hoffman, P., Chmura, S., Connell, P., Juloori, A., Malik, R., Ferguson, M., Patel, J., Vokes, E., Weichselbaum, R., Pitroda, S.

Source: In Journal of Thoracic Oncology March 2021 16(3) Supplement:S341-S342

RO01.01 Prospective Evaluation of Ipilimumab and Nivolumab in Patients with Non-Small Cell Lung Cancer Brain Metastasis

Authors: Juloori, A., Bestvina, C., Pitroda, S., Pointer, K., Jelinek, M., Hoffman, P., Vokes, E., Patel, J., Chmura, S.

Source: In Journal of Thoracic Oncology January 2021 16(1) Supplement:S45-S45

P2.14-12 Tyrosine Kinase Inhibitor Resistance Mechanisms in EGFR T790M-Positive Lung Cancer: The University of Chicago Experience

Authors: Strohbehn, G., Szeto, L., Beach, B., Edgington, K., Lugtu, K., Segal, J., Ritterhouse, L., Bestvina, C., Vokes, E., Patel, J.

Source: In Journal of Thoracic Oncology October 2019 14(10) Supplement:S833-S834

P2.04-12 Ph I Trial of Concurrent or Sequential Ipilimumab, Nivolumab, and SBRT to Multiple Sites in Patients with Stage IV NSCLC

Authors: Patel, J., Jelinek, M., Bestvina, C., Pitroda, S., Vokes, E., Chmura, S.

Source: In Journal of Thoracic Oncology October 2019 14(10) Supplement:S712-S712

MA11.11 STK11/LKB1 Genomic Alterations Are Associated with Inferior Clinical Outcomes with Chemo-Immunotherapy in Non-Squamous NSCLC

Authors: Skoulidis, F., Arbour, K., Hellmann, M., Patil, P., Marmarelis, M., Owen, D., Awad, M., Murray, J., Levy, B., Hellyer, J., Gainor, J., Stewart, T., Goldberg, S., Dimou, A., Bestvina, C., Cummings, A., Elamin, Y., Lam, V., Zhang, J., Shu, C., Riess, J., Blakely, C., Pecot, C., Mezquita, L., Tabbò, F., Sacher, A., Scheffler, M., Ricciuti, B., Venkatraman, D., Rizvi, H., Liu, C., Johnston, R., Ni, Y., Azok, J., Kier, M., Katz, S., Davies, K., Segal, J., Ritterhouse, L., Shaish, H., Lacroix, L., Memmott, R., Madrigal, J., Goldman, J., Lau, S., Killam, J., Walther, Z., Carter, B., Woodcock, M., Roth, J., Swisher, S., Leighl, N., Digumarthy, S., Mooradian, M., Rotow, J., Wolf, J., Scagliotti, G., Planchard, D., Besse, B., Bivona, T., Gandara, D., Garon, E., Rizvi, N., Camidge, D.R., Schalper, K., Herbst, R., Shaw, A., Neal, J., Wakelee, H., Brahmer, J., Jänne, P., Carbone, D., Aggarwal, C., Pennell, N., Rudin, C., Papadimitrakopoulou, V., Heymach, J.

Source: In Journal of Thoracic Oncology October 2019 14(10) Supplement:S294-S295

MA21.11 Epigenomic Mapping of Cell-Free DNA in Patients with Non-Small Cell Lung Cancer

Authors: Bestvina, C., Karpus, J., Cui, X., Oosterbaan, C., Won, B., He, C., Patel, J.

Source: In Journal of Thoracic Oncology October 2018 13(10) Supplement:S432-S433

MA 03.09 The Cost and the Benefit: Front-Line Immunotherapy for Non-Small Cell Lung Cancer

Authors: Bestvina, C., Vokes, E., Hoffman, P., Patel, J.

Source: In Journal of Thoracic Oncology November 2017 12(11) Supplement 2:S1810-S1810

This result is not displayed to guests.
Login for full access.

This result is not displayed to guests.
Login for full access.